BRPI0807384A2 - Método de uma etapa para detecção direta ou simultânea de uma célula cancerosa ou elemento de célula cancerosa em uma amostra biológica, kit para uso em um método, base de dados, método para indetificar células cancerosas, e, uso de uma base de dados. - Google Patents
Método de uma etapa para detecção direta ou simultânea de uma célula cancerosa ou elemento de célula cancerosa em uma amostra biológica, kit para uso em um método, base de dados, método para indetificar células cancerosas, e, uso de uma base de dados. Download PDFInfo
- Publication number
- BRPI0807384A2 BRPI0807384A2 BRPI0807384-8A BRPI0807384A BRPI0807384A2 BR PI0807384 A2 BRPI0807384 A2 BR PI0807384A2 BR PI0807384 A BRPI0807384 A BR PI0807384A BR PI0807384 A2 BRPI0807384 A2 BR PI0807384A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- markers
- agents
- cells
- specific
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90398607P | 2007-02-27 | 2007-02-27 | |
US60/903986 | 2007-02-27 | ||
PCT/EP2008/001542 WO2008104380A2 (fr) | 2007-02-27 | 2008-02-27 | Détection multiple de cellules tumorales utilisant plusieurs agents se fixant à des marqueurs extracellulaires |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0807384A2 true BRPI0807384A2 (pt) | 2014-05-20 |
Family
ID=37945326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0807384-8A BRPI0807384A2 (pt) | 2007-02-27 | 2008-02-27 | Método de uma etapa para detecção direta ou simultânea de uma célula cancerosa ou elemento de célula cancerosa em uma amostra biológica, kit para uso em um método, base de dados, método para indetificar células cancerosas, e, uso de uma base de dados. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110312511A1 (fr) |
EP (2) | EP2126579A2 (fr) |
JP (1) | JP5409395B2 (fr) |
CN (1) | CN101669031A (fr) |
BR (1) | BRPI0807384A2 (fr) |
DK (1) | DK2472264T3 (fr) |
HU (1) | HUE028487T2 (fr) |
RU (1) | RU2489720C2 (fr) |
SI (1) | SI2472264T1 (fr) |
WO (1) | WO2008104380A2 (fr) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
JP6257125B2 (ja) | 2008-11-17 | 2018-01-10 | ベラサイト インコーポレイテッド | 疾患診断のための分子プロファイリングの方法および組成物 |
US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
EP3360978A3 (fr) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Procédés pour le diagnostic d'affections thyroïdiennes |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
JP5610125B2 (ja) * | 2010-02-22 | 2014-10-22 | 国立大学法人 長崎大学 | 癌転移の検出方法および検出用キット |
JP5433517B2 (ja) * | 2010-07-14 | 2014-03-05 | 株式会社日立ハイテクノロジーズ | 解析装置及び解析方法 |
DK2829881T3 (en) * | 2010-07-14 | 2017-12-04 | Vision Tech Bio Pty Ltd | Colorectal cancer diagnostic |
SG191028A1 (en) | 2010-12-06 | 2013-07-31 | Thd Spa | Method for the diagnosis of a carcinoma and uses thereof |
JP6375230B2 (ja) | 2012-02-27 | 2018-08-15 | セルラー リサーチ, インコーポレイテッド | 分子計数のための組成物およびキット |
EP2833149B1 (fr) | 2012-03-28 | 2018-10-03 | On-chip Biotechnologies Co., Ltd. | Procédé de détection du degré de malignité d'une unité de cellule tumorale circulante et trousse pour celui-ci |
US20140045196A1 (en) * | 2012-08-13 | 2014-02-13 | University Of Tokyo | Methods of prognosis and diagnosis of cancer |
JP5221825B1 (ja) * | 2012-10-09 | 2013-06-26 | コニカミノルタホールディングス株式会社 | 肺扁平上皮癌の検出方法 |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
WO2014144826A1 (fr) | 2013-03-15 | 2014-09-18 | Beckman Coulter, Inc. | Systèmes et procédés pour conception de panneau en cytométrie de flux |
JP6352912B2 (ja) * | 2013-06-21 | 2018-07-04 | 国立大学法人 岡山大学 | 異常活性化細胞検出による悪性腫瘍の検査方法および異常活性化細胞除去環流返血治療装置 |
KR20230074639A (ko) | 2013-08-28 | 2023-05-30 | 벡톤 디킨슨 앤드 컴퍼니 | 대량의 동시 단일 세포 분석 |
CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
CN107208158B (zh) | 2015-02-27 | 2022-01-28 | 贝克顿迪金森公司 | 空间上可寻址的分子条形编码 |
EP4180535A1 (fr) | 2015-03-30 | 2023-05-17 | Becton, Dickinson and Company | Procédés et compositions pour codage à barres combinatoire |
WO2016172373A1 (fr) | 2015-04-23 | 2016-10-27 | Cellular Research, Inc. | Procédés et compositions pour l'amplification de transcriptome entier |
JP6940484B2 (ja) | 2015-09-11 | 2021-09-29 | セルラー リサーチ, インコーポレイテッド | ライブラリー正規化のための方法および組成物 |
US10301677B2 (en) | 2016-05-25 | 2019-05-28 | Cellular Research, Inc. | Normalization of nucleic acid libraries |
US10640763B2 (en) | 2016-05-31 | 2020-05-05 | Cellular Research, Inc. | Molecular indexing of internal sequences |
US10202641B2 (en) | 2016-05-31 | 2019-02-12 | Cellular Research, Inc. | Error correction in amplification of samples |
KR102638006B1 (ko) | 2016-09-26 | 2024-02-20 | 셀룰러 리서치, 인크. | 바코딩된 올리고뉴클레오티드 서열을 갖는 시약을 이용한 단백질 발현의 측정 |
EP3577232A1 (fr) | 2017-02-01 | 2019-12-11 | Cellular Research, Inc. | Amplification sélective au moyen d'oligonucléotides de blocage |
CN107058226A (zh) * | 2017-04-01 | 2017-08-18 | 云南赫斯提雅生物科技有限公司 | 准确快速捕获循环肿瘤细胞的方法 |
KR102438495B1 (ko) | 2017-06-05 | 2022-09-01 | 백톤 디킨슨 앤드 컴퍼니 | 단일 세포를 위한 샘플 인덱싱 |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
WO2019213237A1 (fr) | 2018-05-03 | 2019-11-07 | Becton, Dickinson And Company | Codage à barres moléculaire sur des extrémités de transcrit en regard |
EP3788171B1 (fr) | 2018-05-03 | 2023-04-05 | Becton, Dickinson and Company | Analyse multi-omique d'échantillons à haut débit |
CN108619494B (zh) * | 2018-05-13 | 2020-05-05 | 吉林大学 | 促黑激素重组毒素在制备治疗结肠癌药物中的应用 |
EP3572812A1 (fr) * | 2018-05-25 | 2019-11-27 | Bayer Aktiengesellschaft | Procédé de diagnostic de l'endométriose basé sur la diminution du niveau de la protéine microglobuline bêta 2 et la détermination de d'un ou plusieurs biomarqueurs supplémentaires |
US11639517B2 (en) | 2018-10-01 | 2023-05-02 | Becton, Dickinson And Company | Determining 5′ transcript sequences |
WO2020097315A1 (fr) | 2018-11-08 | 2020-05-14 | Cellular Research, Inc. | Analyse transcriptomique complète de cellules uniques à l'aide d'un amorçage aléatoire |
US11492660B2 (en) | 2018-12-13 | 2022-11-08 | Becton, Dickinson And Company | Selective extension in single cell whole transcriptome analysis |
TWI758670B (zh) * | 2018-12-24 | 2022-03-21 | 奎克生技光電股份有限公司 | 健康風險評估方法 |
WO2020154247A1 (fr) | 2019-01-23 | 2020-07-30 | Cellular Research, Inc. | Oligonucléotides associés à des anticorps |
CN114051534A (zh) | 2019-07-22 | 2022-02-15 | 贝克顿迪金森公司 | 单细胞染色质免疫沉淀测序测定 |
US11773436B2 (en) | 2019-11-08 | 2023-10-03 | Becton, Dickinson And Company | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing |
EP4090763A1 (fr) | 2020-01-13 | 2022-11-23 | Becton Dickinson and Company | Procédés et compositions pour la quantification de protéines et d'arn |
RU2727251C2 (ru) * | 2020-01-31 | 2020-07-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ диагностики сторожевых лимфоузлов при раке желудка |
CN111583994A (zh) * | 2020-05-12 | 2020-08-25 | 达州市中心医院 | 肿瘤标志物截断值联合模型及其应用 |
CN115605614A (zh) | 2020-05-14 | 2023-01-13 | 贝克顿迪金森公司(Us) | 用于免疫组库谱分析的引物 |
US11932901B2 (en) | 2020-07-13 | 2024-03-19 | Becton, Dickinson And Company | Target enrichment using nucleic acid probes for scRNAseq |
CN116635533A (zh) | 2020-11-20 | 2023-08-22 | 贝克顿迪金森公司 | 高表达的蛋白和低表达的蛋白的谱分析 |
CN116794313B (zh) * | 2023-08-18 | 2023-11-03 | 江西赛基生物技术有限公司 | 基于流式细胞仪同时检测三项肿瘤标志物的试剂盒及方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO308755B1 (no) * | 1996-12-20 | 2000-10-23 | Iystein Fodstad | FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten |
WO1999041613A1 (fr) * | 1998-02-12 | 1999-08-19 | Immunivest | Methodes et reactifs pour l'isolation rapide et efficace de cellules cancereuses circulantes |
SE9903895D0 (sv) * | 1999-10-28 | 1999-10-28 | Active Biotech Ab | Novel compounds |
JP5433840B2 (ja) * | 2000-09-09 | 2014-03-05 | ザ・リサーチ・ファウンデーション・フォー・ザ・ステイト・ユニヴァーシティ・オブ・ニューヨーク | 転移癌細胞を単離するための方法および組成物、ならびに癌の転移能の測定におけるその使用 |
JP2005501236A (ja) * | 2001-08-23 | 2005-01-13 | イムニベスト・コーポレイション | 分析用の細胞および生物学的検体の安定化 |
JP2007519612A (ja) * | 2003-10-15 | 2007-07-19 | イスティチュート スペリオーレ ディ サニータ | 結腸直腸癌抗原 |
US20090118175A1 (en) * | 2005-05-06 | 2009-05-07 | Macina Roberto A | Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer |
BRPI0520483A2 (pt) * | 2005-08-19 | 2009-11-10 | Indivumed Gmbh | método para detectar adenoma colorretal e/ou carcinoma colorretal, método para discriminar entre adenoma colorretal e carcinoma colorretal ou estados adicionais de tumor, método para monitorar desenvolvimento e/ou curso e/ou tratamento de adenoma colorretal e/ou carcinoma colorretal e/ou a discriminação entre diferentes estágios de tumor, uso de fragmento de endoplasmina, sistema de teste, arranjo, método para determinar se um composto é eficaz no tratamento de adenoma colorretal e/ou carcinoma colorretal e/ou estágios especìficos de tumor |
EP2041299A4 (fr) * | 2006-07-14 | 2010-01-13 | Aviva Biosciences Corp | Procedes et compositions servant a detecter des cellules rares dans un echantillon biologique |
-
2008
- 2008-02-27 CN CN200880006450A patent/CN101669031A/zh active Pending
- 2008-02-27 SI SI200831578A patent/SI2472264T1/sl unknown
- 2008-02-27 HU HUE12002007A patent/HUE028487T2/en unknown
- 2008-02-27 EP EP08716076A patent/EP2126579A2/fr not_active Ceased
- 2008-02-27 EP EP12002007.8A patent/EP2472264B1/fr not_active Not-in-force
- 2008-02-27 BR BRPI0807384-8A patent/BRPI0807384A2/pt not_active Application Discontinuation
- 2008-02-27 JP JP2009551929A patent/JP5409395B2/ja not_active Expired - Fee Related
- 2008-02-27 WO PCT/EP2008/001542 patent/WO2008104380A2/fr active Application Filing
- 2008-02-27 DK DK12002007.8T patent/DK2472264T3/en active
- 2008-02-27 US US12/528,849 patent/US20110312511A1/en not_active Abandoned
- 2008-02-27 RU RU2009135780/15A patent/RU2489720C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2008104380A3 (fr) | 2008-11-27 |
EP2472264A3 (fr) | 2012-10-17 |
RU2489720C2 (ru) | 2013-08-10 |
US20110312511A1 (en) | 2011-12-22 |
DK2472264T3 (en) | 2016-02-29 |
JP5409395B2 (ja) | 2014-02-05 |
CN101669031A (zh) | 2010-03-10 |
JP2011503520A (ja) | 2011-01-27 |
HUE028487T2 (en) | 2016-12-28 |
WO2008104380A2 (fr) | 2008-09-04 |
EP2472264A2 (fr) | 2012-07-04 |
EP2472264B1 (fr) | 2015-11-25 |
RU2009135780A (ru) | 2011-04-10 |
SI2472264T1 (sl) | 2016-06-30 |
EP2126579A2 (fr) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0807384A2 (pt) | Método de uma etapa para detecção direta ou simultânea de uma célula cancerosa ou elemento de célula cancerosa em uma amostra biológica, kit para uso em um método, base de dados, método para indetificar células cancerosas, e, uso de uma base de dados. | |
Granato et al. | Role of HE4, CA72. 4, and CA125 in monitoring ovarian cancer | |
Kulasingam et al. | Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer | |
Song et al. | A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma | |
Zhao et al. | CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression | |
US20120295814A1 (en) | CA-125 Immune Complexes as Biomarkers of Ovarian Cancer | |
Popov et al. | Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications | |
US20180180617A1 (en) | Intergrin alpha v beta 6 for diagnosis/prognosis of colorectal carcinoma | |
Sokoll et al. | Tumor markers | |
Amirghofran et al. | Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis | |
Zhang et al. | Monitoring value of serum HER2 as a predictive biomarker in patients with metastatic breast cancer | |
US10145850B2 (en) | Assay | |
Tas et al. | Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer | |
CN110139656A (zh) | 作为膀胱癌的生物标志物的角蛋白17 | |
CN116121392A (zh) | 用于胰腺囊性肿瘤诊断的方法和试剂 | |
Henno et al. | Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG) | |
US11791043B2 (en) | Methods of prognosing early stage breast lesions | |
EP2694971B1 (fr) | Analyses de récepteurs de stéroïdes pour la détection de cellules cancéreuses | |
Karlsson et al. | Detection of metastatic colon cancer cells in sentinel nodes by flow cytometry | |
Cserni | Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium | |
Rustamadji et al. | Exploring the Integrated Role of AKT2, CD44v6, And MT1-MMP as Predictors of Axillary Lymph Node Metastasis in Invasive Breast Carcinoma of No Special Type | |
Huang et al. | Clinical diagnostic and prognostic value of plasma Hsp90α in invasive breast cancer | |
Sarli et al. | Relationship study of the verified human epidermal growth factor receptor 2 amplification with other tumor markers and clinicohistopathological characteristics in patients with invasive breast cancer, using chromogenic in situ hybridization | |
Moonen et al. | Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics | |
Jiang et al. | Differential Expression of Blood Group Precursor Antigen in Human Breast Cancer Tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |